These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24973521)

  • 21. Canonical and new generation anticancer drugs also target energy metabolism.
    Rodríguez-Enríquez S; Gallardo-Pérez JC; Hernández-Reséndiz I; Marín-Hernández A; Pacheco-Velázquez SC; López-Ramírez SY; Rumjanek FD; Moreno-Sánchez R
    Arch Toxicol; 2014 Jul; 88(7):1327-50. PubMed ID: 24792321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Met kinase inhibitor E7050 reverses three different mechanisms of hepatocyte growth factor-induced tyrosine kinase inhibitor resistance in EGFR mutant lung cancer.
    Wang W; Li Q; Takeuchi S; Yamada T; Koizumi H; Nakamura T; Matsumoto K; Mukaida N; Nishioka Y; Sone S; Nakagawa T; Uenaka T; Yano S
    Clin Cancer Res; 2012 Mar; 18(6):1663-71. PubMed ID: 22317763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer.
    Homma S; Ishii Y; Morishima Y; Yamadori T; Matsuno Y; Haraguchi N; Kikuchi N; Satoh H; Sakamoto T; Hizawa N; Itoh K; Yamamoto M
    Clin Cancer Res; 2009 May; 15(10):3423-32. PubMed ID: 19417020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
    Traxler P; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
    J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer.
    Guo L; Zhou Y; Sun Y; Zhang F
    Eur J Cancer; 2010 Feb; 46(3):636-41. PubMed ID: 20004564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of HER family signaling as a mechanism of acquired resistance to ALK inhibitors in EML4-ALK-positive non-small cell lung cancer.
    Tanizaki J; Okamoto I; Okabe T; Sakai K; Tanaka K; Hayashi H; Kaneda H; Takezawa K; Kuwata K; Yamaguchi H; Hatashita E; Nishio K; Nakagawa K
    Clin Cancer Res; 2012 Nov; 18(22):6219-26. PubMed ID: 22843788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient PI3K inhibition induces apoptosis and overcomes HGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancer.
    Donev IS; Wang W; Yamada T; Li Q; Takeuchi S; Matsumoto K; Yamori T; Nishioka Y; Sone S; Yano S
    Clin Cancer Res; 2011 Apr; 17(8):2260-9. PubMed ID: 21220474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells.
    Brünner-Kubath C; Shabbir W; Saferding V; Wagner R; Singer CF; Valent P; Berger W; Marian B; Zielinski CC; Grusch M; Grunt TW
    Breast Cancer Res Treat; 2011 Sep; 129(2):387-400. PubMed ID: 21046231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leveraging growth factor induced macropinocytosis for targeted treatment of lung cancer.
    Iglesias R; Koria P
    Med Oncol; 2015 Dec; 32(12):259. PubMed ID: 26519258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular ATP and Macropinocytosis: Their Interactive and Mutually Supportive Roles in Cell Growth, Drug Resistance, and EMT in Cancer.
    Evers M; Song J; Chen X
    Subcell Biochem; 2022; 98():61-83. PubMed ID: 35378703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Warburg effect or reverse Warburg effect? A review of cancer metabolism.
    Xu XD; Shao SX; Jiang HP; Cao YW; Wang YH; Yang XC; Wang YL; Wang XS; Niu HT
    Oncol Res Treat; 2015; 38(3):117-22. PubMed ID: 25792083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profiling of Nutrient Transporter Expression in Human Stem Cell-Derived Cardiomyocytes Exposed to Tyrosine Kinase Inhibitor Anticancer Drugs Using RBD Ligands.
    Li J; Cousin C; Tinkler H; Touhami J; Petit V; Thomas N
    J Biomol Screen; 2014 Sep; 19(8):1185-92. PubMed ID: 24809354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors.
    Davidson SM; Jonas O; Keibler MA; Hou HW; Luengo A; Mayers JR; Wyckoff J; Del Rosario AM; Whitman M; Chin CR; Condon KJ; Lammers A; Kellersberger KA; Stall BK; Stephanopoulos G; Bar-Sagi D; Han J; Rabinowitz JD; Cima MJ; Langer R; Vander Heiden MG
    Nat Med; 2017 Feb; 23(2):235-241. PubMed ID: 28024083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer metabolism: the volatile signature of glycolysis-in vitro model in lung cancer cells.
    Feinberg T; Herbig J; Kohl I; Las G; Cancilla JC; Torrecilla JS; Ilouze M; Haick H; Peled N
    J Breath Res; 2017 Jan; 11(1):016008. PubMed ID: 28068289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular adenosine triphosphate as a measure of human tumor cell viability and drug modulated growth.
    Ahmann FR; Garewal HS; Schifman R; Celniker A; Rodney S
    In Vitro Cell Dev Biol; 1987 Jul; 23(7):474-80. PubMed ID: 3610945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Ursolic Acid Derived Small Molecule Triggers Cancer Cell Death through Hyperstimulation of Macropinocytosis.
    Sun L; Li B; Su X; Chen G; Li Y; Yu L; Li L; Wei W
    J Med Chem; 2017 Aug; 60(15):6638-6648. PubMed ID: 28678485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug resistance and combating drug resistance in cancer.
    Wang X; Zhang H; Chen X
    Cancer Drug Resist; 2019; 2(2):141-160. PubMed ID: 34322663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uses and abuses of macropinocytosis.
    Bloomfield G; Kay RR
    J Cell Sci; 2016 Jul; 129(14):2697-705. PubMed ID: 27352861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Dual Role of Macropinocytosis in Cancers: Promoting Growth and Inducing Methuosis to Participate in Anticancer Therapies as Targets.
    Song S; Zhang Y; Ding T; Ji N; Zhao H
    Front Oncol; 2020; 10():570108. PubMed ID: 33542897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.